Our study constructed an accurate and efficient predictive model for MRS, confirmed the correlation of the radiomics signature and tumor-infiltrating myeloid cells, further revealed the prognostic value of iMRS for survival, and assessed the association of iMRS with the outcome of anti-PD-1 and PD-L1 therapy in HCC. This evidence concerns the gene CD274 and neoplasm.